Proteins & Peptides

Amyloid peptides, derived from amyloid precursor protein (APP), are thought to play a role in the development of the senile plaques associated with Alzheimer’s disease. The amyloid hypothesis presupposes that flaws in the processing of APP result in abnormally high levels of the longer, “stickier” forms of beta amyloid, known as Aβ42 and Aβ43, leading to aggregation of amyloid in the neuronal cell death and ultimately neuronal death. Mutations in the structure of Aβ40 and related peptides as well as in some of the enzymes involved in the processing of APP have been shown to alter the processing of APP. The sporadic (i.e., non-genetic) form of the disease, however, is far more common, caused by aging in concert with a number of both genetic and environmental risk factors.

Amyloid peptides, derived from amyloid precursor protein (APP), are thought to play a role in the development of the senile plaques associated with Alzheimer’s disease. The amyloid hypothesis presupposes that flaws in the processing of APP result in abnormally high levels of the longer, “stickier” forms of beta amyloid, known as Aβ42 and Aβ43, leading to aggregation of amyloid in the neuronal cell death and ultimately neuronal death. Mutations in the structure of Aβ40 and related peptides as well as in some of the enzymes involved in the processing of APP have been shown to alter the processing of APP. The sporadic (i.e., non-genetic) form of the disease, however, is far more common, caused by aging in concert with a number of both genetic and environmental risk factors.

Pool of 23 HLA class I restricted T cell epitopes from human cytomegalovirus, Epstein-Barr virus and influenza virus. Stimulates the release of IFN-gamma from CD8+ T cells in individuals with certain highly frequent HLA types (HLA: A1, A2, A3, A11, A24, A68, B7, B8, B27, B35, B44). Chosen epitopes are presented by the most common Caucasian HLA types, whose cumulative frequencies represent >100% of Caucasian individuals. Useful as a peptide specific positive control in ELISPOT, CTL and intracellular cytokine assays using human PBMC.

Pool of 32 HLA class I restricted T cell epitopes from human cytomegalovirus, Epstein-Barr virus and influenza virus. Stimulates the release of IFN-gamma from CD8+ T cells in individuals with certain highly frequent HLA types (HLA: A1, A2, A3, A11, A24, A68, B7, B8, B27, B35, B44). Chosen epitopes are presented by the most common Caucasian HLA types, whose cumulative frequencies represent >100% of Caucasian individuals. Useful as a peptide specific positive control in ELISPOT, CTL and intracellular cytokine assays using human PBMC.

Apelin (APLN) is an endogenous ligand for APJ, an alternative coreceptor with CD4 for HIV-1 infection. It inhibits HIV-1 entry in cells coexpressing CD4 and APJ. It is widely expressed in various organs. Apelin-36 has a greater inhibitory activity on HIV infection than other synthetic apelin derivatives. The oral intake in the colostrum and the milk could have a role in the modulation of the immune responses in neonates. May also have a role in the central control of body fluid homeostasis by influencing AVP release and drinking behavior. Recently, 46 different apelin peptides ranging from apelin 55 (proapelin) to apelin 12 have been identified in bovine colostrum.

Apelin (APLN) is an endogenous ligand for APJ, an alternative coreceptor with CD4 for HIV-1 infection. It inhibits HIV-1 entry in cells coexpressing CD4 and APJ. It is widely expressed in various organs. Apelin-36 has a greater inhibitory activity on HIV infection than other synthetic apelin derivatives. The oral intake in the colostrum and the milk could have a role in the modulation of the immune responses in neonates. May also have a role in the central control of body fluid homeostasis by influencing AVP release and drinking behavior. Recently, 46 different apelin peptides ranging from apelin 55 (proapelin) to apelin 12 have been identified in bovine colostrum.

Apelin (APLN) is an endogenous ligand for APJ, an alternative coreceptor with CD4 for HIV-1 infection. It inhibits HIV-1 entry in cells coexpressing CD4 and APJ. It is widely expressed in various organs. Apelin-36 has a greater inhibitory activity on HIV infection than other synthetic apelin derivatives. The oral intake in the colostrum and the milk could have a role in the modulation of the immune responses in neonates. May also have a role in the central control of body fluid homeostasis by influencing AVP release and drinking behavior. Recently, 46 different apelin peptides ranging from apelin 55 (proapelin) to apelin 12 have been identified in bovine colostrum.

Apelin (APLN) is an endogenous ligand for APJ, an alternative coreceptor with CD4 for HIV-1 infection. It inhibits HIV-1 entry in cells coexpressing CD4 and APJ. It is widely expressed in various organs. Apelin-36 has a greater inhibitory activity on HIV infection than other synthetic apelin derivatives. The oral intake in the colostrum and the milk could have a role in the modulation of the immune responses in neonates. May also have a role in the central control of body fluid homeostasis by influencing AVP release and drinking behavior. Recently, 46 different apelin peptides ranging from apelin 55 (proapelin) to apelin 12 have been identified in bovine colostrum.

Apelin (APLN) is an endogenous ligand for APJ, an alternative coreceptor with CD4 for HIV-1 infection. It inhibits HIV-1 entry in cells coexpressing CD4 and APJ. It is widely expressed in various organs. Apelin-36 has a greater inhibitory activity on HIV infection than other synthetic apelin derivatives. The oral intake in the colostrum and the milk could have a role in the modulation of the immune responses in neonates. May also have a role in the central control of body fluid homeostasis by influencing AVP release and drinking behavior. Recently, 46 different apelin peptides ranging from apelin 55 (proapelin) to apelin 12 have been identified in bovine colostrum.